From Health Canada:
Important Safety Information Regarding the Antiparkinson Drug Permax® (pergolide mesylate): Sudden Onset of Sleep
Shire BioChem Inc., in association with Health Canada, would like to inform you of important safety information pertaining to Permax® (pergolide mesylate), a dopamine agonist, indicated for the treatment of the signs and symptoms of early and advanced idiopathic Parkinson’s disease. As reported previously for other dopaminergic agents indicated in the treatment of Parkinson’s disease1, this safety information advises of the possibility of patients suddenly falling asleep while performing daily activities, including driving a car, while receiving treatment with Permax (pergolide mesylate). Somnolence is a known potential side effect of Permax (pergolide mesylate), but the occurrence of sudden onset of sleep during daily activities has been rarely reported.

From the Maryland Gazette:
Forum scheduled on drugs from Canada
A forum on the proposed purchase of prescription drugs from Canada for county employees and retirees will be held Monday.

The forum, hosted by County Councilman Thomas E. Perez (D-Dist. 5) of Takoma Park, will be held at 7 p.m. in the third-floor hearing room of the Stella B. Werner County Council Office Building at 100 Maryland Ave. in Rockville.